Search details
1.
Efficacy and Safety of Panitumumab in Patients With RAF/RAS-Wild-Type Glioblastoma: Results From the Drug Rediscovery Protocol.
Oncologist
; 29(5): 431-440, 2024 May 03.
Article
in English
| MEDLINE | ID: mdl-38109296
2.
Next generation sequencing of high-grade adult-type diffuse glioma in the Netherlands: interlaboratory variation in the primary diagnostic and recurrent setting.
J Neurooncol
; 166(3): 485-492, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-38285243
3.
Limited clinical activity of palbociclib and ribociclib monotherapy in advanced cancers with cyclin D-CDK4/6 pathway alterations in the Dutch DRUP and Australian MoST trials.
Int J Cancer
; 153(7): 1413-1422, 2023 10 01.
Article
in English
| MEDLINE | ID: mdl-37424386
4.
Prevalence and Predictors of Physician-Patient Discordance in Prognostic Perceptions in Advanced Cancer.
Oncologist
; 28(8): e653-e668, 2023 08 03.
Article
in English
| MEDLINE | ID: mdl-37159001
5.
Dabrafenib plus trametinib in patients with BRAFV600E-mutant low-grade and high-grade glioma (ROAR): a multicentre, open-label, single-arm, phase 2, basket trial.
Lancet Oncol
; 23(1): 53-64, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34838156
6.
Characteristics of patients with advanced cancer preferring not to know prognosis: a multicenter survey study.
BMC Cancer
; 22(1): 941, 2022 Sep 01.
Article
in English
| MEDLINE | ID: mdl-36050628
7.
Perfusion imaging with arterial spin labeling (ASL)-MRI predicts malignant progression in lowgrade (WHO grade II) gliomas.
Neuroradiology
; 63(12): 2023-2033, 2021 Dec.
Article
in English
| MEDLINE | ID: mdl-34114065
8.
Phase 1 study of the pan-HER inhibitor dacomitinib plus the MEK1/2 inhibitor PD-0325901 in patients with KRAS-mutation-positive colorectal, non-small-cell lung and pancreatic cancer.
Br J Cancer
; 122(8): 1166-1174, 2020 04.
Article
in English
| MEDLINE | ID: mdl-32147669
9.
Effect of a Skills Training for Oncologists and a Patient Communication Aid on Shared Decision Making About Palliative Systemic Treatment: A Randomized Clinical Trial.
Oncologist
; 25(3): e578-e588, 2020 03.
Article
in English
| MEDLINE | ID: mdl-32162796
10.
Reducing uncertainty: motivations and consequences of seeking a second opinion in oncology.
Acta Oncol
; 59(12): 1512-1519, 2020 Dec.
Article
in English
| MEDLINE | ID: mdl-32702254
11.
Training for Medical Oncologists on Shared Decision-Making About Palliative Chemotherapy: A Randomized Controlled Trial.
Oncologist
; 24(2): 259-265, 2019 02.
Article
in English
| MEDLINE | ID: mdl-29959285
12.
Bevacizumab and temozolomide in patients with first recurrence of WHO grade II and III glioma, without 1p/19q co-deletion (TAVAREC): a randomised controlled phase 2 EORTC trial.
Lancet Oncol
; 19(9): 1170-1179, 2018 09.
Article
in English
| MEDLINE | ID: mdl-30115593
13.
Prevalence of symptoms in glioma patients throughout the disease trajectory: a systematic review.
J Neurooncol
; 140(3): 485-496, 2018 Dec.
Article
in English
| MEDLINE | ID: mdl-30377935
14.
Venous thromboembolism and intracranial hemorrhage after craniotomy for primary malignant brain tumors: a National Surgical Quality Improvement Program analysis.
J Neurooncol
; 136(1): 135-145, 2018 Jan.
Article
in English
| MEDLINE | ID: mdl-29039075
15.
A dose escalating phase I study of GLPG0187, a broad spectrum integrin receptor antagonist, in adult patients with progressive high-grade glioma and other advanced solid malignancies.
Invest New Drugs
; 34(2): 184-92, 2016 Apr.
Article
in English
| MEDLINE | ID: mdl-26792581
16.
Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial.
Lancet Oncol
; 15(9): 943-53, 2014 Aug.
Article
in English
| MEDLINE | ID: mdl-25035291
17.
Focused Ultrasound-Enhanced Liquid Biopsy: A Promising Diagnostic Tool for Brain Tumor Patients.
Cancers (Basel)
; 16(8)2024 Apr 19.
Article
in English
| MEDLINE | ID: mdl-38672658
18.
Potential Adverse Outcomes of Shared Decision Making about Palliative Cancer Treatment: A Secondary Analysis of a Randomized Trial.
Med Decis Making
; 44(1): 89-101, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-37953598
19.
Baseline and on Treatment Biodistribution Variability of 18F-FLT Uptake in Patients With Advanced Melanoma: Brief Communication.
Clin Nucl Med
; 2024 May 15.
Article
in English
| MEDLINE | ID: mdl-38768063
20.
The Predictive Value of FDG PET/CT for Determining Progression-Free Survival in Advanced Stage III-IV BRAF -Mutated Melanoma Patients Treated With Targeted Therapy-What Can Be Learned From Progression?
Clin Nucl Med
; 49(2): 138-145, 2024 Feb 01.
Article
in English
| MEDLINE | ID: mdl-38113329